Ad is loading...
IPEAX
Price
$6.02
Change
-$0.02 (-0.33%)
Updated
Nov 15 closing price
VIVAX
Price
$68.72
Change
-$0.26 (-0.38%)
Updated
Nov 15 closing price
Ad is loading...

IPEAX vs VIVAX

Header iconIPEAX vs VIVAX Comparison
Open Charts IPEAX vs VIVAXBanner chart's image
Voya Large Cap Value Port A
Price$6.02
Change-$0.02 (-0.33%)
VolumeN/A
CapitalizationN/A
Vanguard Value Index I
Price$68.72
Change-$0.26 (-0.38%)
VolumeN/A
CapitalizationN/A
IPEAX vs VIVAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
IPEAX vs. VIVAX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IPEAX is a Buy and VIVAX is a StrongSell.

FUNDAMENTALS
Fundamentals
VIVAX has more cash in the bank: 184B vs. IPEAX (613M). VIVAX pays higher dividends than IPEAX: VIVAX (2.25) vs IPEAX (1.54). IPEAX was incepted earlier than VIVAX: IPEAX (18 years) vs VIVAX (32 years). IPEAX has a lower initial minimum investment than VIVAX: IPEAX (0) vs VIVAX (3000). VIVAX annual gain was more profitable for investors over the last year : 25.55 vs. IPEAX (22.99). VIVAX return over 5 years is better than : 50.81 vs. IPEAX (-44.68).
IPEAXVIVAXIPEAX / VIVAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence18 years32 years-
Gain YTD13.84017.91277%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets613M184B0%
Annual Yield % from dividends1.542.2568%
Returns for 1 year22.9925.5590%
Returns for 3 years-54.1421.58-251%
Returns for 5 years-44.6850.81-88%
Returns for 10 years-43.20110.46-39%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
POR46.650.76
+1.66%
Portland General Electric Company
UMH19.16-0.17
-0.85%
UMH Properties
YQ1.86-0.02
-1.11%
17 Education & Technology Group
FICO2261.00-62.17
-2.68%
Fair Isaac Corp
PSTX2.76-0.45
-14.02%
Poseida Therapeutics